Tygacil Hospital Antibiotic Launch Expected Within 12 Months
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth hopes to launch the injectable antibiotic Tygacil (tigecycline) within the next 12 months, CEO Robert Essner told the Bear Stearns conference in New York Sept. 14.